BridgeMD
New treatment option for Massive Rotator Cuff Tears
Official title Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.
ClinicalTrials.gov ID: NCT04571918
What this study is testing
- What it's testing
- Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 85
You may be able to join if
- Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by...
- Persistent pain for at least 3 months, with documented failure of conservative treatment
- Age ranging from 60 years of age to 85 years of age
You likely can't join if
- Significant shoulder osteoarthritis in the affected shoulder, Hamada classification \>2.
- Total rupture of subscapularis tendon and/or teres minor, classified B and E in the Collins classification.
- Comorbidity to the degree that the patient will not be able to participate in the follow up program.
The study team makes the final eligibility decision.
Where it's taking place
- Arendal, Norway
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Arendal, Norway; Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.